journal article·2017-05-24Open access

P-gp Inhibition and Mitochondrial Impairment by Dual-Functional Nanostructure Based on Vitamin E Derivatives To Overcome Multidrug Resistance

Ruslan G. Tuguntaev, Shizhu Chen, Ahmed Shaker Eltahan, Anbu Mozhi, Shubin Jin, Jinchao Zhang, Chan Li, Paul C. Wang, Xing-Jie Liang

Abstract

Vitamin E derivatives possess many essential features for drug-delivery applications, such as biocompatibility, stability, improvement of water solubility of hydrophobic compounds, anticancer activity, and the ability to overcome multidrug resistance (MDR). Herein, vitamin E derivatives are used to overcome MDR through a combined P-glycoprotein (P-gp) inhibition and mitochondrial impairment strategy. A novel nanomicellar drug-delivery system as a carrier for doxorubicin (DOX) was developed, in which d-α-tocopheryl polyethylene glycol 1000 succinate was used as a P-gp inhibitor, α-tocopheryl succinate was introduced as a mitochondrial disrupting agent, and d-α-tocopheryl polyethylene glycol 2000 succinate was used as the main building block of micelles. The optimal ratio between the components of the nanocarrier was determined. The resultant DOX-loaded mixed micelles exhibited a suitable size of 52.08 nm, high drug-loading encapsulation efficiency (>98%), high stability, and pH-dependent drug release. In vitro experiments demonstrated a significantly increased cytotoxic activity of DOX-loaded mixed micelles against resistant MCF-7/Adr cells (45-fold higher than DOX after 48 h of treatment). In vivo studies revealed superior antitumor efficiency with less cardio- and hepatotoxicities of DOX-loaded micelles compared with that of free DOX. These results highlight that the developed DOX-loaded mixed micelles have a promising potential to overcome MDR in chemotherapy for clinical usage.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Drug Transport and Resistance Mechanisms · Metal complexes synthesis and properties

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

University of Chinese Academy of Sciences, Beijing 100049, P. R. China

College of Chemistry & Environmental Science, Key Laboratory of Medicinal Chemistry and Molecular Diagnosis of the Ministry of Education, Chemical Biology Key Laboratory of Hebei Province, Hebei University, Baoding 071002, P. R. China

Beijing Municipal Institute of Labour Protection, No. 55 Taoranting Road, Xicheng District, Beijing 100054, P. R. China

Fu Jen Catholic University, Taipei, 24205, Taiwan

Laboratory of Molecular Imaging, Department of Radiology, Howard University, Washington, D.C. 20060, United States

Funding

Natural Science Foundation of Beijing Municipality · Bureau of International Cooperation, Chinese Academy of Sciences · National Natural Science Foundation of China · The World Academy of Sciences · Chinese Academy of Sciences

References (29)

Show source-provided references
1. Chorawala M. · Int. J. Pharm. Sci. Drug Res. · 2012 · 4 · 110.25004/IJPSDR.2012.040101 ↗
2. 10.1038/sj.onc.120694810.1038/sj.onc.1206948 ↗
3. 10.1517/14622416.2.1.5110.1517/14622416.2.1.51 ↗
4. 10.1016/j.jare.2014.11.00810.1016/j.jare.2014.11.008 ↗
5. 10.1016/j.febslet.2006.02.02010.1016/j.febslet.2006.02.020 ↗
6. 10.1016/j.jconrel.2014.03.00910.1016/j.jconrel.2014.03.009 ↗
7. 10.1021/mp060121r10.1021/mp060121r ↗
8. 10.1021/mp900191s10.1021/mp900191s ↗
9. 10.1016/j.jconrel.2005.11.00510.1016/j.jconrel.2005.11.005 ↗
10. Wu S. H.-W. · Pharm. Technol. · 1999 · 23 · 52
11. 10.1021/acs.molpharmaceut.5b0012910.1021/acs.molpharmaceut.5b00129 ↗
12. 10.1016/j.mam.2007.02.00310.1016/j.mam.2007.02.003 ↗
13. 10.1054/bjoc.2000.155910.1054/bjoc.2000.1559 ↗
14. 10.1038/sj.bjc.660136010.1038/sj.bjc.6601360 ↗
15. 10.1016/j.actbio.2015.06.01410.1016/j.actbio.2015.06.014 ↗
16. 10.1016/j.colsurfb.2012.08.06210.1016/j.colsurfb.2012.08.062 ↗
17. 10.1016/j.biomaterials.2011.02.02210.1016/j.biomaterials.2011.02.022 ↗
18. 10.1021/acsami.5b0499510.1021/acsami.5b04995 ↗
19. 10.1016/j.ijpharm.2014.09.02810.1016/j.ijpharm.2014.09.028 ↗
20. 10.1002/anie.20140303610.1002/anie.201403036 ↗
21. 10.1016/s0168-3659(99)00248-510.1016/s0168-3659(99)00248-5 ↗
22. 10.1016/s0169-409x(00)00124-110.1016/s0169-409x(00)00124-1 ↗
23. 10.1016/j.biomaterials.2012.03.04610.1016/j.biomaterials.2012.03.046 ↗
24. 10.1021/nl400586t10.1021/nl400586t ↗
25. 10.1023/a:101500050362910.1023/a:1015000503629 ↗
26. 10.1016/j.nantod.2011.02.00310.1016/j.nantod.2011.02.003 ↗
27. 10.1172/jci7293110.1172/jci72931 ↗
28. Doroshow J. H. · Res. Commun. Chem. Pathol. Pharmacol. · 1979 · 26 · 285
29. 10.1055/s-2000-1112410.1055/s-2000-11124 ↗